COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2581-4710

Online ISSN:-2581-4729

CODEN : IIJCBS

Current Issue

Year 2020

Volume: 6 , Issue: 1

Article Access statistics

Viewed: 137

Emailed: 0

PDF Downloaded: 99

IP Indian Journal of Clinical and Experimental Dermatology


Evaluation of efficacy and safety of intradermal PPD for treating facial warts - A prospective study


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Karaninder Singh Mehta*, Pushpinder Singh Chauhan, Monika Chandel, Vikram Mahajan, Bhumika Chaudhary

Volume : 5, Issue : 4, Year : 2019

Article Page : 322-326


Suggest article by email

Abstract

Introduction: Commonly used destructive treatment modalities for treatment of warts though effective,
are associated with pain, pigmentary changes, scarring and recurrences. Utilization of various vaccines and
skin test antigens has broaden the horizon of available immunotherapeutic armamentarium for the treatment
of warts.
Aim: Evaluation of efficacy and safety of intradermal PPD for treating facial warts - a prospective study..
Materials and Methods: Fifty-four patients with facial warts were treated with intradermal injections
of PPD 10 TU/0.1 ml at two weekly intervals. They were followed up at 2, 4, 6, 8, and 12 weeks for
assessment of response, adverse effects and recurrence of facial warts.
Results: Out of 54 (M: F 25:29) patients, only 49 patients with facial warts completed the study. Overall,
complete clearance in 22(45%) patients and partial clearance in 18(37%) patients were observed. The
patients with complete/partial clearance were highly satisfied from the treatment. Recurrence was not seen
in our patients. Few patients had injection site pain for 2-3 days not warranting discontinuation of treatment.
Other adverse effects included temporary erythema and swelling in 3 patients which subsided on its own in
2-3 days.
Conclusion: 82% patients responded (complete and partial response) to therapy. Intradermal PPD appears
effective, safe, and acceptable treatment modality for facial warts. It carries the advantage of patient
compliance, insignificant adverse effects and high patient satisfaction.

Keywords: Warts, Purified protein derivative, Intradermal, Immunotherapy.

Doi : 10.18231/j.ijced.2019.067

How to cite : Mehta K S, Chauhan P S, Chandel M, Mahajan V, Chaudhary B, Evaluation of efficacy and safety of intradermal PPD for treating facial warts - A prospective study. IP Indian J Clin Exp Dermatol 2019;5(4):322-326

Copyright © 2019 by author(s) and IP Indian J Clin Exp Dermatol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)